PMID: 8976830Aug 1, 1996Paper

Differences in clinical manifestations of genital chlamydial infections related to serovars

Genitourinary Medicine
M J van de LaarJ A van den Hoek

Abstract

To study the association of serovars of Chlamydia trachomatis with clinical manifestations of genital tract infection and socio-demographic characteristics. In 1986-88 the C trachomatis isolates from 159 heterosexual men and 116 women attending a sexually transmitted disease (STD) clinic were collected and typed accordingly. A medical history was recorded, a physical examination took place and samples were taken for laboratory diagnostics. Serovars E, F and D were the most common for both men (75%) and women (67%). Men infected with serovars of the C-complex had more often a history of STD (p = 0.06). The opposite was demonstrated in women (p = 0.07). In addition, women younger than 18 years at first intercourse were more often infected with C-complex serovars (p = 0.05). For men, the serovars F/G less often produced symptoms of urethral discharge (p = 0.01) than the serovars of the B-complex and C-complex and were less often associated with the presence of 10 or more leukocytes in a Gram-stained smear (p = 0.04). In this study, infections with serovars F and G caused less obvious symptoms and signs of inflammation in men; in women no differences were found in the clinical manifestation of infections with different serovars.

References

Feb 23, 1978·The New England Journal of Medicine·J Schachter
Jul 1, 1975·The Journal of Infectious Diseases·J T Grayston, S Wang
Dec 1, 1992·The Journal of Infectious Diseases·K A WorkowskiW E Stamm
Feb 1, 1991·The Journal of Infectious Diseases·S P Wang, J T Grayston
Apr 1, 1991·Genitourinary Medicine·H Näher, D Petzoldt
Sep 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Persson, S Osser
Aug 1, 1989·The Journal of Infectious Diseases·B E BatteigerR B Jones
Oct 10, 1987·Lancet·D Sanyal, S Oates
Oct 1, 1987·The Journal of Pediatrics·M FisherM H Kaplan
Jun 1, 1988·Genitourinary Medicine·J H WagenvoortW E Stamm
Dec 1, 1987·The Journal of Infectious Diseases·R C BarnesW E Stamm
Nov 1, 1985·The Journal of Infectious Diseases·R C BarnesW E Stamm
Oct 1, 1985·The Journal of Infectious Diseases·S P WangJ T Grayston
Jul 23, 1981·The New England Journal of Medicine·T C QuinnK K Holmes
Oct 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K A WorkowskiW E Stamm
Sep 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J M OssewaardeA M van Loon
May 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E ChungueS P Wang
Dec 1, 1995·Genitourinary Medicine·Y T van DuynhovenJ A van den Hoek

❮ Previous
Next ❯

Citations

Sep 29, 2009·Journal of Bacteriology·Alexandra NunesJoão P Gomes
May 16, 1998·Genitourinary Medicine·M J BorregoM A Catry
Mar 1, 2011·Enfermedades infecciosas y microbiología clínica·Maria de Jesús De Haro-CruzFernando M Guerra-Infante
Dec 25, 2010·Journal of Medical Microbiology·Ana C S MachadoCarolyn M Black
Mar 19, 2011·Journal of Medical Microbiology·Hamid JalalChristopher Sonnex
Mar 14, 2009·FEMS Immunology and Medical Microbiology·Lisbeth Nørum PedersenJens Kjølseth Møller
Oct 10, 2012·FEMS Microbiology Letters·Kimberly A BlivenAnthony T Maurelli
Nov 20, 2016·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jyoti RawreRama Chaudhry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.